Jump to content

Topical decongestant

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Irruptive Creditor (talk | contribs) at 01:49, 22 August 2023. The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Topical decongestants are decongestants applied directly to the nasal cavity. Their effectiveness by themselves in the common cold appears to have a small benefit in adults.[1]

Topical decongestants should only be used by patients for a maximum of 5–7 days in a row, because rebound congestion may occur in the form of rhinitis medicamentosa. When used in adults for a short period of time side effects appear to be few.[1]

Mechanism of action

[edit]

Topical decongestants are vasoconstrictors, and work by constricting the blood vessels within the nasal cavity.

Examples

[edit]

See also

[edit]

References

[edit]
  1. ^ a b Deckx, L; De Sutter, AI; Guo, L; Mir, NA; van Driel, ML (17 October 2016). "Nasal decongestants in monotherapy for the common cold". The Cochrane Database of Systematic Reviews. 10: CD009612. doi:10.1002/14651858.CD009612.pub2. PMC 6461189. PMID 27748955.